John Duerden, MD
Foot and Ankle Surgery · Chesapeake, VANPI 1922195858
Payments from drug & device makers
Across 67 payments — averaging $83.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Bioventus LLC$665
- Fortis Surgical, LLC$545
- Medtronic$147
- Smith+Nephew$126
- KCI USA, Inc.$99
- plus $756 from 21 others
What the payments were for
- Travel & lodging$88516%
- Food & beverage$2,02036%
- Education$2,69148%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $3,258 |
| Bioventus LLC | 15 | $665 |
| Fortis Surgical, LLC | 4 | $545 |
| Medtronic | 2 | $147 |
| Smith+Nephew | 1 | $126 |
| KCI USA, Inc. | 1 | $99 |
| Dynasplint Systems Inc. | 3 | $78 |
| Abbott | 2 | $74 |
| Fidia Pharma USA Inc. | 4 | $70 |
| Convatec Inc. | 3 | $59 |
| Stryker | 2 | $56 |
| Lifenet Health | 2 | $56 |
| Radius Health, Inc. | 2 | $49 |
| Restor3d, Inc. | 1 | $36 |
| Si-bone, Inc. | 1 | $34 |
| Painteq LLC | 1 | $33 |
| Vertex | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Zimmer Biomet | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Innovation Technologies Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,596 in reported general payments places this provider in the 60th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 52 | $390 |
| Meloxicam | 116 | $342 |
| Diclofenac Sodium | 33 | $293 |
| Naproxen | 33 | $236 |
| Methylprednisolone | 27 | $179 |
| Duloxetine Hcl | 11 | $124 |
| Oxycodone Hcl | 25 | $123 |
| Ondansetron Hcl | 28 | $105 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $103 |
| Ibuprofen | 17 | $66 |
| Tramadol Hcl | 17 | $54 |
| Prednisone | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Chesapeake
- Jessica BrunoChesapeake$17K
- Bryan ScottChesapeake$15K
- Rex DiazChesapeake$12K
- Charles ZelenRoanoke$6.2M
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$1.2M
- Matthew DairmanSuffolk$376K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.